- Home
- BVS vs NMAI Comparison
BVS vs NMAI Comparison
Compare BVS & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BVS | NMAI |
|---|---|---|
| Founded | 2011 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.1M | 433.5M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | BVS | NMAI |
|---|---|---|
| Price | $10.56 | $13.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 440.5K | 109.2K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | ★ 163.46 | N/A |
| EPS | 0.33 | ★ 0.64 |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $7.06 | N/A |
| P/E Ratio | $32.03 | ★ $21.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $11.31 |
| 52 Week High | $10.58 | $13.96 |
Technical Indicators
Market Signals| Indicator | BVS | NMAI |
|---|---|---|
| Relative Strength Index (RSI) | 74.48 | 65.60 |
| Support Level | $8.43 | $13.43 |
| Resistance Level | N/A | $13.90 |
| Average True Range (ATR) | 0.36 | 0.25 |
| MACD | 0.14 | 0.16 |
| Stochastic Oscillator | 94.99 | 90.50 |
Price Performance
Historical ComparisonAbout BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund's investment objective is to provide total return through high current income and capital appreciation.